Fl. Yang et Ra. Disilvestro, EFFECTS OF DIETARY ZINC RESTRICTION ON BISMUTH INDUCTION OF RAT-KIDNEY METALLOTHIONEIN, Journal of nutritional biochemistry, 7(4), 1996, pp. 196-199
Bismuth-stimulated elevation of metallothionein levels is proposed to
inhibit side effects of chemotherapy drugs such as cisplatin and adria
mycin. In the present study, low zinc intake by rats limited bismuth-i
nduced accumulation of renal metallothionein protein, and metallothion
ein-associated zinc and bismuth. In contrast, bismuth strongly elevate
d metallothionein mRNA in rats fed low zinc. Thus, bismuth does not ap
pear to require zinc to stimulate high metallothionein mRNA accumulati
on, bur seems to need this metal to accumulate metallothionein protein
. Therefore, the efficacy of bismuth in restricting chemotherapy drug
side effects in humans may depend on the zinc status of the people und
er treatment.